Lumos Pharma Inc. Stock Forecast
Lumos Pharma Inc. stock upgraded from Sell Candidate to Buy Candidate after Tuesday trading session.
(Updated on Apr 23, 2024)
The Lumos Pharma Inc. stock price gained 4.48% on the last trading day (Tuesday, 23rd Apr 2024), rising from $2.68 to $2.80. During the last trading day the stock fluctuated 5.56% from a day low at $2.70 to a day high of $2.85. The price has risen in 5 of the last 10 days and is up by 4.09% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 15 thousand more shares were traded than the day before. In total, 20 thousand shares were bought and sold for approximately $55.01 thousand.
The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $2.84 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -12.17% during the next 3 months and, with a 90% probability hold a price between $2.12 and $2.49 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
LUMO Signals & Forecast
The Lumos Pharma Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.60 and $2.78. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 14.29%. Further rise is indicated until a new top pivot has been found. Lumos Pharma Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Lumos Pharma Inc. stock
Lumos Pharma Inc. finds support from accumulated volume at $2.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.150 between high and low, or 5.56%. For the last week, the stock has had daily average volatility of 8.00%.
Our recommended stop-loss: $2.69 (-3.96%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)
Trading Expectations (LUMO) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Lumos Pharma Inc. to open at $2.78, and during the day (based on 14 day Average True Range), to move between $2.62 and $2.98, which gives a possible trading interval of +/-$0.176 (+/-6.27%) up or down from last closing price. If Lumos Pharma Inc. takes out the full calculated possible swing range there will be an estimated 12.55% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.70 (3.57%) than the resistance at $3.01 (7.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Lumos Pharma Inc. will release earnings BMO on Wednesday, May 01, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.21. We will update the financials statements for Lumos Pharma Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.47% in the first trading day after earnings release.
Is Lumos Pharma Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 1.753 Buy Candidate Upgraded
Predicted Opening Price for Lumos Pharma Inc. of Wednesday, April 24, 2024
| Fair opening price April 24, 2024 | Current price |
|---|---|
| $2.78 ( 0.595%) | $2.80 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for LUMO
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.93 | 4.76 % | |
| R2 | 2.88 | 2.72 % | ||
| R1 | 2.84 | 1.45 % | ||
| Current price: | 2.80 | |||
| Support | S1 | 2.73 | -2.64 % | |
| S2 | 2.69 | -3.91 % | ||
| S3 | 2.63 | -5.95 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.05 | 8.93 % | |
| R2 | 3.04 | 8.57 % | ||
| R1 | 3.01 | 7.50 % | ||
| Current price | 2.80 | |||
| Support | S1 | 2.70 | -3.57% | |
| S2 | 2.65 | -5.36% | ||
| S3 | 2.52 | -10.00% |
FAQ
Click here for our free guide on how to buy Lumos Pharma Inc. Stock.
